ZIMMER BIOMET HOLDINGS, INC. (NYSE:ZBH) Files An 8-K Submission of Matters to a Vote of Security HoldersItem 5.07
Submission of Matters to a Vote of Security Holders
ZIMMER BIOMET HOLDINGS, INC. (NYSE:ZBH) Files An 8-K Submission of Matters to a Vote of Security Holders
Zimmer Biomet Holdings, Inc. (the “Company”) held its annual meeting of shareholders on May 15, 2018.Shareholders took the following actions:
|
elected nine (9) directors for one-year terms ending at the 2019 annual meeting of shareholders (Proposal1); |
|
ratified the Audit Committee’s appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for 2018 (Proposal 2); and |
|
approved, on an advisory basis, the compensation of the Company’s named executive officers as disclosed in the Company’s proxy statement (Proposal 3). |
The vote tabulation for each proposal follows:
Proposal 1 – Election of Directors
|
Nominee |
For |
Against |
Abstained |
Broker Non-Votes |
|
Christopher B. Begley |
160,254,308 |
643,499 |
135,080 |
14,621,693 |
|
Betsy J. Bernard |
158,930,818 |
1,950,061 |
152,008 |
14,621,693 |
|
Gail K. Boudreaux |
159,022,587 |
1,860,833 |
149,467 |
14,621,693 |
|
Michael J. Farrell |
158,814,927 |
2,059,435 |
158,525 |
14,621,693 |
|
Larry C. Glasscock |
157,507,457 |
3,365,367 |
160,063 |
14,621,693 |
|
Robert A. Hagemann |
159,818,782 |
1,074,417 |
139,688 |
14,621,693 |
|
Bryan C. Hanson |
160,156,645 |
737,391 |
138,851 |
14,621,693 |
|
Arthur J. Higgins |
124,667,635 |
36,228,637 |
136,615 |
14,621,693 |
|
Michael W. Michelson |
160,234,599 |
656,124 |
142,164 |
14,621,693 |
Proposal 2 – Ratification of the Appointment of the Independent Registered Public Accounting Firm
|
For |
Against |
Abstained |
Broker Non-Votes |
|
173,027,223 |
2,484,868 |
142,489 |
Proposal 3 – Advisory Vote to Approve Named Executive Officer Compensation (“Say on Pay”)
|
For |
Against |
Abstained |
Broker Non-Votes |
|
150,630,503 |
10,007,744 |
394,640 |
14,621,693 |
About ZIMMER BIOMET HOLDINGS, INC. (NYSE:ZBH)
Zimmer Biomet Holdings, Inc., formerly Zimmer Holdings, Inc., is engaged designing, manufacturing and marketing orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants, and related surgical products. The Company’s products and solutions helps treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. The Company manages its operations through three geographic operating segments: the Americas, consists of the United States and includes other North, Central and South American markets; EMEA, consists of Europe and includes the Middle East and African markets, and Asia Pacific, consists of Japan and includes other Asian and Pacific markets. Its four product category segments include Americas Spine, Bone Healing Craniomaxillofacial and Thoracic, and Dental.